Assessment of regulatory needs list

Assessment of regulatory needs list

The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed. 

For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.

The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.  

Last updated 13 September 2021. Database contains 268 unique substances/entries.
Filter the list
Date of intention:
Date of RMOA conclusion:
Latest update:

The List does not contain any Substances.
 
242-060-2
18172-67-3
Greece
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/07/2017
Details
256-032-2
42978-66-5
Sweden
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
15/08/2017
Details
show/hide
Trimethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane EC / List no: 288-657-1 | CAS no: 85857-16-5
Triethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane EC / List no: 257-473-3 | CAS no: 51851-37-7
-
-
Denmark
Respiratory sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
06/02/2015
Details
246-932-3
25387-93-3
Denmark
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
13/09/2021
Details
230-528-9
7173-62-8
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
26/04/2019
Details
253-242-6
36861-47-9
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
253-242-6
36861-47-9
Denmark
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
26/05/2021
Details
690-137-8
5436-43-1
France
Endocrine disruption
Concluded
No need to initiate further regulatory risk management action at this time
Other
23/08/2019
Details
271-094-0
68515-51-5
Sweden
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
13/01/2015
Details
431-890-2
166412-78-8
France
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
15/03/2016
Details
203-444-5
106-93-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
Other legislation
07/08/2015
Details
201-152-2
78-87-5
Netherlands
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
09/11/2017
Details
214-946-9
1222-05-5
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
28/01/2020
Details
220-474-4
2778-42-9
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
211-463-5
646-06-0
Germany
Carcinogenic
Mutagenic
Respiratory sensitiser
STOT RE
Toxic for reproduction
Under development
Under development
No suggestion yet
24/06/2020
Details
214-317-9
1120-71-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
06/02/2015
Details
204-661-8
123-91-1
Germany
Bioaccumulation
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Restriction
23/06/2020
Details
221-641-4
3173-72-6
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
10/10/2019
Details
covering any of its individual anti- and syn-isomers or any combination thereof
-
-
United Kingdom
Bioaccumulation
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/08/2018
Details
240-260-4
16096-31-4
Denmark
Persistence
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
239-139-9
15087-24-8
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
203-439-8
106-89-8
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
212-828-1
872-50-4
Commission
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
25/10/2018
Details
214-012-0
1072-63-5
Sweden
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/01/2020
Details
205-028-9
131-55-5
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
201-236-9
79-94-7
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Pending
On hold
No suggestion yet
01/04/2015
Details
219-799-4
2536-05-2
Denmark
Carcinogenic
Mutagenic
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
10/10/2019
Details
219-799-4
2536-05-2
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
401-720-1
6807-17-6
Sweden
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
17/05/2018
Details
221-967-7
3296-90-0
Norway
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/01/2020
Details
show/hide
2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionyl fluoride EC / List no: 218-173-8 | CAS no: 2062-98-8
2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionic acid EC / List no: 236-236-8 | CAS no: 13252-13-6
Potassium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionate EC / List no: 266-578-3 | CAS no: 67118-55-2
Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoate EC / List no: 700-242-3 | CAS no: 62037-80-3
799-974-4
-
Netherlands
Other environmental toxicity
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
SVHC
14/06/2019
Details
219-154-7
2374-14-3
Netherlands
Bioaccumulation
Other human toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
CLH
10/07/2015
Details
SR-245
426-040-2
25713-60-4
Netherlands
Bioaccumulation
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
23/09/2014
Details
223-383-8
3864-99-1
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
205-029-4
131-56-6
Denmark
Endocrine disruption
Under development
Under development
No suggestion yet
23/09/2014
Details
201-841-8
88-58-4
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
204-881-4
128-37-0
France
Carcinogenic
Endocrine disruption
Exposure
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
17/01/2019
Details
274-570-6
70321-86-7
Germany
Endocrine disruption
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details
221-573-5
3147-75-9
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details
253-037-1
36437-37-3
Germany
Bioaccumulation
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
422-600-5
73936-91-1
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details
219-470-5
2440-22-4
Germany
Other human toxicity
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
05/12/2014
Details
201-289-8
80-54-6
Sweden
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
02/09/2019
Details
404-360-3
119313-12-1
Austria
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
25/11/2020
Details
260-829-0
57583-35-4
Netherlands
Bioaccumulation
Other human toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
05/07/2017
Details
239-622-4
15571-58-1
Austria
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/12/2019
Details
203-080-7
103-11-7
Sweden
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
15/08/2017
Details
203-772-9
110-49-6
Sweden
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
29/11/2018
Details
400-600-6
71868-10-5
Austria
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
25/11/2020
Details
220-239-6
2682-20-4
Denmark
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
04/05/2015
Details

Export search results to:

EU Privacy Disclaimer

This website uses cookies to ensure you get the best experience on our websites.